News
Men meldingerne får ikke analytiker i Handelsbanken Capital Markets, Klaus Ørtoft Madsen, op af stolen. "Markedet havde frygtet en nedjustering og vidste, at salget af Epoq havde været svagt. William ...
Narrow-moat Demant announced that the UK Competition and Markets Authority's provisional finding (prior to the final report in early June) is that the divestment of Oticon Medical to Cochlear Ltd ...
Investing.com -- Shares of Demant A/S (CSE:DEMANT) fell 5.5% as the company reported a soft revenue dynamic, despite a 4% ...
In 2021, Demant reported revenues of 512 million Danish kroner, or about $72 million, for its hearing implant business. That’s less than 3% of the company’s entire revenue for the year, which ...
The big shareholder groups in Demant A/S (CPH:DEMANT) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often ...
Hearing aid maker William Demant is looking for more retail acquisitions to increase control over the sale of its products and fight competition from discount chains such as Costco. The group will ...
The CMA has set a June 5 deadline for its in-depth phase 2 probe into Cochlear's purchase of Demant's Oticon Medical business. Reuters Published On Mar 20, 2023 at 07:15 PM IST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results